1. Home
  2. ACXP vs NXPL Comparison

ACXP vs NXPL Comparison

Compare ACXP & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • NXPL
  • Stock Information
  • Founded
  • ACXP 2017
  • NXPL 1997
  • Country
  • ACXP United States
  • NXPL United States
  • Employees
  • ACXP N/A
  • NXPL N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • NXPL Telecommunications Equipment
  • Sector
  • ACXP Health Care
  • NXPL Telecommunications
  • Exchange
  • ACXP Nasdaq
  • NXPL Nasdaq
  • Market Cap
  • ACXP 8.4M
  • NXPL 17.9M
  • IPO Year
  • ACXP 2021
  • NXPL N/A
  • Fundamental
  • Price
  • ACXP $0.49
  • NXPL $0.77
  • Analyst Decision
  • ACXP Strong Buy
  • NXPL
  • Analyst Count
  • ACXP 2
  • NXPL 0
  • Target Price
  • ACXP $10.00
  • NXPL N/A
  • AVG Volume (30 Days)
  • ACXP 18.6M
  • NXPL 32.6K
  • Earning Date
  • ACXP 08-08-2025
  • NXPL 08-13-2025
  • Dividend Yield
  • ACXP N/A
  • NXPL N/A
  • EPS Growth
  • ACXP N/A
  • NXPL N/A
  • EPS
  • ACXP N/A
  • NXPL N/A
  • Revenue
  • ACXP N/A
  • NXPL $62,515,000.00
  • Revenue This Year
  • ACXP N/A
  • NXPL N/A
  • Revenue Next Year
  • ACXP N/A
  • NXPL N/A
  • P/E Ratio
  • ACXP N/A
  • NXPL N/A
  • Revenue Growth
  • ACXP N/A
  • NXPL 19.36
  • 52 Week Low
  • ACXP $0.30
  • NXPL $0.43
  • 52 Week High
  • ACXP $3.33
  • NXPL $2.30
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 51.01
  • NXPL 62.83
  • Support Level
  • ACXP $0.46
  • NXPL $0.68
  • Resistance Level
  • ACXP $0.56
  • NXPL $0.85
  • Average True Range (ATR)
  • ACXP 0.10
  • NXPL 0.07
  • MACD
  • ACXP -0.01
  • NXPL 0.00
  • Stochastic Oscillator
  • ACXP 24.27
  • NXPL 61.74

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: